The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Zantel Cat and Dog Tablets

50/500 mg/tablet Tablet

Chanelle Pharmaceuticals Manufacturing LimitedVPA10987/052/001

Main Information

Trade NameZantel Cat and Dog Tablets
Active SubstancesPraziquantel
Fenbendazole
Strength50/500 mg/tablet
Dosage FormTablet
Licence HolderChanelle Pharmaceuticals Manufacturing Limited
Licence NumberVPA10987/052/001

Group Information

ATC CodeQP52AA51 praziquantel, combinations
QP52AC13 fenbendazole
Therapeutic ClassEndoparasiticide
SpeciesCats
Dogs

Status

Authorised/WithdrawnAuthorised
Licence Issued04/05/2001
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back